CONMED Corporation to Announce Third Quarter 2019 Financial Results on October 30, 2019 – BioSpace

Posted: October 7, 2019 at 6:47 pm

This post was added by Alex Diaz-Granados

Oct. 7, 2019 20:01 UTC

UTICA, N.Y.--(BUSINESS WIRE)-- ConMed Corporation (NASDAQ:CNMD) today announced that it will report financial results for the third quarter of 2019 after the market close on Wednesday, October 30, 2019. The Companys management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

To participate in the conference call, dial 1-844-889-7792 (domestic) or +1-661-378-9936 (international) and refer to the passcode 8990458.

This conference call will also be webcast and can be accessed from the Investors section of CONMED's website at http://www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A recording of the call will also be available from 7:30 p.m. ET on Wednesday, October 30, 2019, until 6:30 p.m. ET on Thursday, November 14, 2019. To hear this recording, dial 1-855-859-2056 (domestic) or +1-404-537-3406 (international) and enter the passcode 8990458.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Companys products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. For more information, visit http://www.conmed.com.

Forward-Looking Statements

This press release and the October 30, 2019 conference call may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risk factors discussed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018, and listed under the heading Forward-Looking Statements in the Companys most recently filed Form 10-Q. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Companys performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that managements expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191007005581/en/

Read the original:

CONMED Corporation to Announce Third Quarter 2019 Financial Results on October 30, 2019 - BioSpace

Related Post
This entry was posted in Medical Technology. Bookmark the permalink.

Comments are closed.